266 related articles for article (PubMed ID: 34323031)
1. [Lipid Metabolic Reprogramming and Metabolic Stress in Liver Cancer].
Xu Z; Yuan KF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):561-565. PubMed ID: 34323031
[TBL] [Abstract][Full Text] [Related]
2. The role of lipid metabolic reprogramming in tumor microenvironment.
Yang K; Wang X; Song C; He Z; Wang R; Xu Y; Jiang G; Wan Y; Mei J; Mao W
Theranostics; 2023; 13(6):1774-1808. PubMed ID: 37064872
[TBL] [Abstract][Full Text] [Related]
3. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment.
Seo J; Yun JE; Kim SJ; Chun YS
Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849
[TBL] [Abstract][Full Text] [Related]
4. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics.
Jin HR; Wang J; Wang ZJ; Xi MJ; Xia BH; Deng K; Yang JL
J Hematol Oncol; 2023 Sep; 16(1):103. PubMed ID: 37700339
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer.
Wang J; Zhang W; Liu C; Wang L; Wu J; Sun C; Wu Q
Int J Biol Sci; 2024; 20(5):1884-1904. PubMed ID: 38481820
[TBL] [Abstract][Full Text] [Related]
6. Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy.
Zhang M; Wei T; Zhang X; Guo D
Front Immunol; 2022; 13():937406. PubMed ID: 36131916
[TBL] [Abstract][Full Text] [Related]
7. RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer.
Li YQ; Sun FZ; Li CX; Mo HN; Zhou YT; Lv D; Zhai JT; Qian HL; Ma F
Mil Med Res; 2023 Jul; 10(1):34. PubMed ID: 37491281
[TBL] [Abstract][Full Text] [Related]
8. Targeting dysregulated lipid metabolism in the tumor microenvironment.
Kim DH; Song NY; Yim H
Arch Pharm Res; 2023 Dec; 46(11-12):855-881. PubMed ID: 38060103
[TBL] [Abstract][Full Text] [Related]
9. Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer.
Guo D; Ye L; Wu W; Yu X; Jin K
Acta Biochim Biophys Sin (Shanghai); 2023 Apr; 55(6):923-937. PubMed ID: 37021976
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy.
Wu Y; Pu X; Wang X; Xu M
Lipids Health Dis; 2024 Feb; 23(1):35. PubMed ID: 38302980
[TBL] [Abstract][Full Text] [Related]
11. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
12. Targeting Lipid Metabolism in Liver Cancer.
Alannan M; Fayyad-Kazan H; Trézéguet V; Merched A
Biochemistry; 2020 Oct; 59(41):3951-3964. PubMed ID: 32930581
[TBL] [Abstract][Full Text] [Related]
13. Non-coding RNAs, metabolic stress and adaptive mechanisms in cancer.
Liu X; Feng S; Zhang XD; Li J; Zhang K; Wu M; Thorne RF
Cancer Lett; 2020 Oct; 491():60-69. PubMed ID: 32726612
[TBL] [Abstract][Full Text] [Related]
14. Integrated transcriptomics and metabolomics analyses to investigate the anticancer mechanisms of cinobufagin against liver cancer through interfering with lipid, amino acid, carbohydrate, and nucleotide metabolism.
Yang A; Wu Q; Wang A; Chen Q; Yang J; Tao Y; Sun Y; Zhang J
Bioorg Chem; 2023 Jan; 130():106229. PubMed ID: 36335648
[TBL] [Abstract][Full Text] [Related]
15. [A Review of the Lipid Metabolism Reprogramming in Tumor Associated Macrophages].
Zhao K; Shi RC; Miao HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jan; 52(1):45-49. PubMed ID: 33474888
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral lipid metabolic reprogramming as a pro-tumoral regulator in the tumor milieu.
Wang R; Hu Q; Wu Y; Guan N; Han X; Guan X
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188962. PubMed ID: 37541532
[TBL] [Abstract][Full Text] [Related]
17. Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review.
Hu B; Lin JZ; Yang XB; Sang XT
Cell Prolif; 2020 Mar; 53(3):e12772. PubMed ID: 32003505
[TBL] [Abstract][Full Text] [Related]
18. Role of Aberrant Lipid Metabolism of Cancer Stem Cells in Cancer Progression.
Zhou J; Zhao J; Su C
Curr Cancer Drug Targets; 2021; 21(8):631-639. PubMed ID: 33726650
[TBL] [Abstract][Full Text] [Related]
19. Lipid Metabolic Regulatory Crosstalk Between Cancer Cells and Tumor-Associated Macrophages.
Liu S; Shen YY; Yin LY; Liu J; Zu X
DNA Cell Biol; 2023 Aug; 42(8):445-455. PubMed ID: 37535386
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the metabolic alteration-modulated tumor microenvironment mediated by TP53 mutation and hypoxia.
Luo K; Qian Z; Jiang Y; Lv D; Zhu K; Shao J; Hu Y; Lv C; Huang Q; Gao Y; Jin S; Shang D
Comput Biol Med; 2023 Sep; 163():107078. PubMed ID: 37356294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
